Stay updated on Pembrolizumab in Elderly Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Elderly Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Elderly Lung Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T08:53:38.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces the previous v3.4.2 on the page.
    Difference
    0.1%
    Check dated 2026-03-12T05:06:28.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    No detectable content changes between the screenshots; the study details page remains the same.
    Difference
    0.1%
    Check dated 2026-02-19T00:34:05.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2 and removes a government funding notice and an older Revision: v3.4.1; these are administrative metadata updates that do not affect study content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T20:38:32.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    A new site-wide notice informs users about potential downtime due to a lapse in government funding and provides the NIH Clinical Center's operating status. The page also shows an updated revision tag, v3.4.1, replacing the previous v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T11:31:24.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    Glossary toggle added; study-record metadata label updated (Last Update Submitted that Met QC Criteria) and a new site revision note (Revision: v3.4.0) introduced, while older QC labels and FEAR data references were removed.
    Difference
    0.2%
    Check dated 2026-01-28T11:09:50.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Elderly Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Elderly Lung Cancer Clinical Trial page.